Treatment With a New Peroxisome Proliferator-Activated Receptor Gamma Agonist, Pyridinecarboxylic Acid Derivative, Increases Angiogenesis and Reduces Inflammatory Mediators in the Heart of Trypanosoma Cruzi-Infected Mice

Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2017.01738

Related search